US2009286287A1PendingUtilityA1
METHODS AND COMPOSITIONS FOR USE IN PREPARRING siRNAs
Est. expiryMay 3, 2022(expired)· nominal 20-yr term from priority
C12N 15/111C12N 2330/30C12N 2310/14C12N 15/113C12N 9/22C12N 2310/53
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions for producing siRNAs, e.g., in the form of a d-siRNA composition, from dsRNAs are provided. In the subject methods, a dsRNA is contacted with a composition that includes an activity that cleaves dsRNA into siRNAs, where the composition efficiently cleaves dsRNA into siRNAs. siRNAs produced by the subject methods find use in a variety of applications, particularly in applications where the specific reduction or silencing of a gene is desired. Also provided are kits for use in practicing the subject invention.
Claims
exact text as granted — not AI-modified1 . A method for producing siRNA from an initial dsRNA, said method comprising:
contacting said dsRNA with a composition enriched for a protein having an activity that cleaves a dsRNA substrate into fragments having siRNA activity to produce said siRNA, wherein said composition efficiently produces siRNAs from dsRNA.
2 . The method according to claim 1 , wherein said method is in vitro.
3 . The method according to claim 1 , wherein said contacting occurs in the absence of ATP.
4 . The method according to claim 1 , wherein said protein is a recombinantly produced protein.
5 . The method according to claim 1 , wherein said protein is full-length Dicer or an active fragment thereof.
6 . The method according to claim 1 , wherein said composition converts at least 80% of said dsRNA to siRNA.
7 . The method according to claim 1 , wherein siRNAs produced by said method range in length from about 20 to 23 residues.
8 . The method according to claim 7 , wherein siRNAs produced by said method are 20-21 residues in length.
9 . The method according to claim 1 , wherein said method produces a d-siRNA preparation of siRNAs from said dsRNA.
10 . A method of at least reducing the expression of a gene in a target cell, said method comprising:
producing an siRNA preparation for said gene using the method of claim 1 ; and introducing into said cell an effective amount of said siRNA preparation to at least reduce expression of said gene.
11 . The method according to claim 10 , wherein said siRNA preparation is a d-siRNA preparation according to claim 9 .
12 . The method according to claim 10 , wherein said method is an in vitro method.
13 . The method according to claim 10 , wherein said method is an in vivo method.
14 . The method according to claim 10 , wherein said method is a method of silencing expression of said gene.
15 . The method according to claim 10 , wherein said method is a loss of function assay.
16 . A kit for use in preparing siRNA from dsRNA, said kit comprising:
a composition enriched for a protein having an activity that cleaves a dsRNA substrate into fragments having siRNA activity to produce said siRNA, wherein said composition efficiently produces siRNAs from dsRNA.
17 . A kit according to claim 16 , wherein said composition is ATP free.
18 . The kit according to claim 16 , wherein said protein is a recombinantly produced protein.
19 . The kit according to claim 16 , wherein said protein is full length dicer or an active fragment thereof.
20 . The kit according to claim 16 , wherein said kit further comprises instructions for practicing a method according to claim 1 .
21 . A d-siRNA preparation producing according to the method claim 1 .Join the waitlist — get patent alerts
Track US2009286287A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.